Adipokines as Drug Targets in Diabetes and Underlying Disturbances
Diabetes and obesity are worldwide health problems. White fat dynamically participates in hormonal and inflammatory regulation. White adipose tissue is recognized as a multifactorial organ that secretes several adipose-derived factors that have been collectively termed “adipokines.” Adipokines are p...
Saved in:
Main Authors: | Vinícius Andrade-Oliveira, Niels O.S. Câmara, Pedro M. Moraes-Vieira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/681612 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adipokines and Hepatic Insulin Resistance
by: Yu Li, et al.
Published: (2013-01-01) -
Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus
by: Nikolaos Vrachnis, et al.
Published: (2012-01-01) -
Polymorphisms in Adipokines in Mexican Children with Obesity
by: Angélica Saraí Jiménez-Osorio, et al.
Published: (2019-01-01) -
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Tania Romacho, et al.
Published: (2013-01-01) -
Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers
by: Mythily Srinivasan, et al.
Published: (2018-01-01)